Mind Medicine (MindMed) Inc.

NASDAQ:MNMD

6.08 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015
Revenue 000000000
Cost of Revenue 3.1623.2232.61600.0070.0070.00600
Gross Profit -3.162-3.223-2.6160-0.007-0.007-0.00600
Gross Profit Ratio 000000000
Reseach & Development Expenses 48.96236.16934.78918.63100000
General & Administrative Expenses 41.74230.16259.06514.39900000
Selling & Marketing Expenses 000000000
SG&A 41.74230.16259.06514.3990.4620.8551.230.1110.095
Other Expenses 00.0020.106000000
Operating Expenses 90.70466.33193.85433.030.4620.8551.230.1110.095
Operating Income -93.866-66.331-96.364-33.03-0.468-0.862-1.235-0.111-0.095
Operating Income Ratio 000000000
Total Other Income Expenses Net -1.8669.5352.171-0.907-0.6480.0040.008-0.0690.002
Income Before Tax -95.732-56.796-94.193-33.937-1.116-0.858-1.227-0.18-0.093
Income Before Tax Ratio 000000000
Income Tax Expense 0-9.535-1.1570.164-0-0-00-0
Net Income -95.732-47.261-93.036-34.101-1.116-0.858-1.227-0.18-0.093
Net Income Ratio 000000000
EPS -2.44-1.53-3.4-1.92-2.94-2.74-4.85-2.24-1.17
EPS Diluted -2.44-1.53-3.4-1.92-2.94-2.74-4.85-2.24-1.17
EBITDA -90.704-74.369-93.748-33.03-0.462-0.855-1.23-0.111-0.095
EBITDA Ratio 000000000